Clinical Translation-2
Introduction
Our Clinical Proteomics Team II is dedicated to in-depth research in the field of early lung cancer diagnosis. We have developed innovative proteomics pre-treatment methods based on microspheres and other cutting-edge technologies, specifically for analyzing body fluid samples. This study integrates multi-omics technologies, including proteomics, metabolomics, and radiomics, and combines them with bioinformatics and clinical research to provide a comprehensive and profound understanding of lung cancer. Through this interdisciplinary approach, we are committed to uncovering the complex mechanisms of lung cancer and advancing the development of early diagnostic techniques.
Members
Team leader: Huanhuan Gao
Team members: Liqin Qian, Zekai Li